Predictive Value of Multimodal MRI in Parkinson's Disease
Multimodal Magnetic Resonance Imaging Studying the Mechanism and Predicting the Outcome After Deep Brain Stimulation in Patients With Parkinson's Disease
1 other identifier
interventional
100
1 country
1
Brief Summary
Deep brain stimulation (DBS) is recognized as the most safe and effective neurosurgical method for the treatment of advanced Parkinson's disease. However, the mechanism of relieving motor and non-motor symptoms of Parkinson's disease has not been fully clarified, and the prognosis is significantly different. This study is based on multimodal MRI technique to clarify the mechanism of DBS in relieving motor and non-motor symptoms of Parkinson's disease, and to explore imaging indicators that can predict prognosis, so as to guide the individual and accurate treatment of Parkinson's disease (PD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 19, 2021
CompletedFirst Submitted
Initial submission to the registry
July 1, 2021
CompletedFirst Posted
Study publicly available on registry
August 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedAugust 12, 2021
July 1, 2021
2 years
July 1, 2021
August 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinical characteristics of patients
Age at onset; age at surgery; disease duration; level of education; comorbidities (e.g. hypertension and diabetes mellitus); parkinsonism subtype; period of motor fluctuations; time from motor fluctuations to surgery; cigarette smoking
1 to 2 years
Percentage of improvement in motor aspects (after 12 months of stimulation)
(UPDRS III 12 months - UPDRS III baseline)/UPDRS III baseline where UPDRS III 12 months means the score of this test in "medication off , stimulation on" condition at 12 months after implant, while UPDRS III baseline means the score of this test in "medication off " condition.The clinical outcome, or degree of symptom benefit, was defined as a ≥50% improvement on a disease severity rating scale
1 to 3 years
Secondary Outcomes (1)
other records:
1 to 3 years
Study Arms (1)
PD,DBS
EXPERIMENTALPatients with idiopathic PD before and after DBS surgery
Interventions
Preoperative and postoperative functional magnetic resonance imaging (fMRI) scanning. fMRI is a new neuroimaging method. Its principle is to use magnetic resonance imaging to measure the changes of hemodynamics caused by neuronal activity.
For PD patients treated with DBS, the neurologist will turn off the stimulator before MRI scan
Eligibility Criteria
You may qualify if:
- Patient with Parkinson's disease
- age\< 70 years
- Underwent bilateral STN-DBS or not
- Having complete medical history and clinical follow up
- All MRI examination performed according to study protocol
- Imaging data can be processed
- Signed informed consent obtained from the patient or patient's legally authorized representative;
You may not qualify if:
- Parkinson-plus syndrome or secondary parkinsonism
- Patients with severe mental disorders such as psychosis, liver and kidney dysfunction, poor blood pressure or blood glucose control, severe depression and substance abuse, low IQ, and acute phase of severe stroke with definite limb dysfunction should also be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chinese PLA General Hospital
Beijing, Beijing Municipality, 100853, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xin Lou
Chinese PLA General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Director of Department of Radiology
Study Record Dates
First Submitted
July 1, 2021
First Posted
August 12, 2021
Study Start
June 19, 2021
Primary Completion
July 1, 2023
Study Completion
July 1, 2025
Last Updated
August 12, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share